Guilford, CT, March 21, 2025. We are excited to announce that Spatomics has entered into a co-marketing agreement with Biocare Medical, a leader in innovative immunohistochemistry instrumentation and reagents. This collaboration aims to promote the compatibility of Spatomics’ CFP™ cleavable TSA fluorophore technology with Biocare’s ONCORE Pro X automated staining platform.
As part of this collaboration, Spatomics has successfully demonstrated 20-plex protein and RNA co-detection on the ONCORE Pro X system. Together, Spatomics and Biocare aim to offer researchers a powerful solution for high-plex spatial biology, combining automated precision with advanced fluorescent signal detection. This partnership represents a shared commitment to making high-plex multiomics spatial biology assays more accessible and efficient for translational and clinical research.
